239 related articles for article (PubMed ID: 24770952)
1. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
[TBL] [Abstract][Full Text] [Related]
2. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature.
Andrassy RJ; Okcu MF; Despa S; Raney RB
J Am Coll Surg; 2001 Mar; 192(3):305-13. PubMed ID: 11245372
[TBL] [Abstract][Full Text] [Related]
3. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
4. Effects of Adjuvant Radiotherapy in Patients With Synovial Sarcoma.
Song S; Park J; Kim HJ; Kim IH; Han I; Kim HS; Kim S
Am J Clin Oncol; 2017 Jun; 40(3):306-311. PubMed ID: 25350464
[TBL] [Abstract][Full Text] [Related]
5. Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.
Stanelle EJ; Christison-Lagay ER; Healey JH; Singer S; Meyers PA; La Quaglia MP
Ann Surg Oncol; 2013 Jan; 20(1):73-9. PubMed ID: 22878620
[TBL] [Abstract][Full Text] [Related]
6. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
Lewis JJ; Antonescu CR; Leung DH; Blumberg D; Healey JH; Woodruff JM; Brennan MF
J Clin Oncol; 2000 May; 18(10):2087-94. PubMed ID: 10811674
[TBL] [Abstract][Full Text] [Related]
7. Localized synovial sarcoma: A single institutional study of 191 patients with a minimum follow-up of 5 years for survivors.
Outani H; Nakamura T; Murata H; Stevenson J; Parry M; Gregory J; Tillman R; Jeys L; Abudu A
J Surg Oncol; 2019 Jun; 119(7):850-855. PubMed ID: 30786036
[TBL] [Abstract][Full Text] [Related]
8. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.
Italiano A; Penel N; Robin YM; Bui B; Le Cesne A; Piperno-Neumann S; Tubiana-Hulin M; Bompas E; Chevreau C; Isambert N; Leyvraz S; du Chatelard PP; Thyss A; Coindre JM; Blay JY
Ann Oncol; 2009 Mar; 20(3):425-30. PubMed ID: 19088169
[TBL] [Abstract][Full Text] [Related]
9. Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.
Wu Y; Bi W; Han G; Jia J; Xu M
World J Surg Oncol; 2017 May; 15(1):101. PubMed ID: 28494784
[TBL] [Abstract][Full Text] [Related]
10. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
[TBL] [Abstract][Full Text] [Related]
11. Synovial sarcoma prognostic factors and patterns of failure.
Paulino AC
Am J Clin Oncol; 2004 Apr; 27(2):122-7. PubMed ID: 15057149
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
[TBL] [Abstract][Full Text] [Related]
13. Synovial sarcoma involving skull base--a retrospective analysis of diagnosis and treatment of 21 cases in one institution.
Ji T; Ma CY; Ow A; Wang LZ; Sun J; Zhang CP
Oral Oncol; 2011 Jul; 47(7):671-6. PubMed ID: 21641853
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.
Crowson MG; Lalich I; Keeney MG; Garcia JJ; Price DL
Head Neck; 2015 Mar; 37(3):375-80. PubMed ID: 24430934
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
17. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
18. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
20. Multivariate analysis of prognostic factors in synovial sarcoma.
Koh KH; Cho EY; Kim DW; Seo SW
Orthopedics; 2009 Nov; 32(11):824. PubMed ID: 19902890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]